Literature DB >> 6317700

Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases.

D J Knauer, J A Thompson, D D Cunningham.   

Abstract

The protease nexins (PN-I, Mr approximately 38,000; PN-II, Mr approximately 95,000; and PN-III, Mr approximately 31,000) are recently described cell-secreted proteins that selectively link to regulatory serine proteases in the extracellular environment and mediate their cellular binding, internalization, and degradation. In the present studies we compared the protease nexins with respect to protease specificity, heparin sensitivity, and general mode of action. By competitive binding assays using [125I]-thrombin, [125I]-nerve growth factor-gamma (125I-NGF-gamma), and [125I]-epidermal growth factor binding protein (125I-EGF-binding protein), we characterized the nexins in terms of protease specificity and determined that PN-I links to and mediates the cellular binding of thrombin or urokinase, whereas PN-II and PN-III preferentially link to and mediate the cellular binding of the EGF binding protein and NGF-gamma, respectively. In addition, whereas the ability of PN-I to link to thrombin is strongly modulated by heparin, PN-II and PN-III are essentially unaffected by heparin. The linkage of each of the nexins to their respective proteases requires the catalytic site serine of the protease, judged by the inability of diisopropylphospho (DIP) derivatives of the proteases tested to link to their respective nexins. Subsequent to linkage, the nexin:protease complexes are bound to cells, rapidly internalized, and ultimately degraded via a monensin-sensitive apparently lysosomal pathway, although each nexin:protease complex is degraded at its own characteristic rate. Importantly, the protease nexins provide the major pathway through which human fibroblasts interact with each of the serine proteases studied. Taken together, these data suggest that the nexins are a unique class of cell-secreted proteins that enable cells to monitor and selectively regulate specific serine proteases in their environment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317700     DOI: 10.1002/jcp.1041170314

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

Review 1.  Molecules that make axons grow.

Authors:  A D Lander
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

Review 2.  Molecular and cellular biology of Alzheimer amyloid.

Authors:  C A Marotta; R E Majocha; B Tate
Journal:  J Mol Neurosci       Date:  1992       Impact factor: 3.444

3.  The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin.

Authors:  H S Suidan; K J Clemetson; M Brown-Luedi; S P Niclou; J M Clemetson; J Tschopp; D Monard
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

4.  Suppression of the degradation of recombinant human apolipoprotein E by a protease inhibitor obtained from fetal bovine serum in serum-free culture.

Authors:  T Shimomura; T Honda; C Oouchi; J Kondo; K Nagaike
Journal:  Cytotechnology       Date:  1991-05       Impact factor: 2.058

5.  A glia-derived neurite-promoting factor with protease inhibitory activity.

Authors:  J Guenther; H Nick; D Monard
Journal:  EMBO J       Date:  1985-08       Impact factor: 11.598

6.  Protease nexin-1 expression is altered in human breast cancer.

Authors:  Britny J Candia; William C Hines; Christopher M Heaphy; Jeffrey K Griffith; Robert A Orlando
Journal:  Cancer Cell Int       Date:  2006-05-31       Impact factor: 5.722

7.  Cellular processing of bovine factors X and Xa by cultured bovine aortic endothelial cells.

Authors:  P P Nawroth; D McCarthy; W Kisiel; D Handley; D M Stern
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

Review 8.  Prostasin: An Epithelial Sodium Channel Regulator.

Authors:  Shakti Aggarwal; Pradeep K Dabla; Sarika Arora
Journal:  J Biomark       Date:  2013-07-02

9.  Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Authors:  Joanna Selzer-Plon; Jette Bornholdt; Stine Friis; Hanne C Bisgaard; Inger Mb Lothe; Kjell M Tveit; Elin H Kure; Ulla Vogel; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.